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Abstract 
Previous literature has established that increases in prescription opioid misuse has 
resulted in similar increases in injection drug use (IDU), collectively referred to as the 
“opioid epidemic” in the US.  Due to this surge in IDU, incidence of Hepatitis C (HCV) 
and Human Immunodeficiency Virus (HIV) are on the rise in many regions. Research 
conducted in Canada and elsewhere has supported the use of Safe Injection Facilities 
(SIFs) and Needle Syringe Programs (NSPs) to mollify disease incidence, but only NSPs 
are operating in the US despite SIFs having been in use in Canada for several decades. As 
little research has been conducted in the US about where SIFs could be of benefit, we 
employ an analytical model to estimate the value of a hypothetical SIF in Kent County, 
Michigan (MI) using local surveillance data. Addition of such a facility was found to 
reduce HCV incidence by 7 cases / year, in addition to decreasing HIV incidence by 5%. 
 
Background 
Treatment for opioid use disorder occupies a precarious space within the 
American legal, medical, and cultural frameworks. In 1971, the “War on Drugs” began in 
earnest, although another three years had passed before the Narcotic Addict Treatment 
Act was signed into law, which established the legality of methadone clinics. Methadone 
(although commonly mistaken for the street drug “meth”, which is an entirely different 
substance whose full name is methamphetamine) is in many ways an ideal drug from 
treating opioid addiction, as its properties allow for the abatement of withdrawal 
symptoms without the euphoric effects of heroin or morphine, which can allow users to 
maintain steady employment and begin rebuilding the social damages caused by 
addiction. Results of this approach were encouraging, but less than two decades later, an 
unrelated report by the American Pain Society advocated that pain was determined to be 
the “fifth vital sign” in medicine. This report argued that physicians to minimize patient 
suffering as much as possible— often relying on opioids to do so1. This effort was well-
                                                        
1 “The 5th Vital Sign and America’s Painkiller Epidemic.” 2016. The University of Arizona Health 
Sciences. April 1, 2016. https://uahs.arizona.edu/blog/2016-04-02/5th-vital-sign-and-
america%E2%80%99s-painkiller-epidemic. 
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intentioned but had side effect of vastly increasing the number of opioids in circulation, 
becoming what many consider to be a prominent cause for today’s current opioid 
epidemic. 
Because of the variance in patient needs and circumstances, it stands to reason 
that a wider array of therapeutic options can result in better individualized treatment and 
outcomes; and indeed congress and the U.S. Food and Drug Administration (FDA) has 
since approved other drugs for therapeutic use: two such being Buprenorphine and 
Naltrexone. Buprenorphine can only be prescribed in a primary care setting, and while as 
an “agonist-antagonist” it has proven effective in achieving abstinence in a short period 
of time, there remain concerns about longer term mortality rates that may be due to 
patient tolerance discrepancies2. Naltrexone, on the other hand, is available as a depot 
injection and as such isn’t subject to the adherence or overdose concerns of oral tablets, 
but has limited effectiveness otherwise3.  
While it is true that these drugs have unique profiles and can be tailored to fit 
specific patient needs, the limitations of an incongruent approach to the broader social, 
economic, and legal context of the opioid crisis has been exacerbated by the alarming 
growth of the epidemic. This calls for stronger efforts to destigmatize addiction in both a 
social and clinical context in order to improve patient retention and adherence to all 
intervention methods. It is for this reason that safe injection facilities (SIFs) have great 
potential. Put plainly, SIFs are clinics that are staffed by licensed physicians and nursing 
staff where opioid users can go, without legal consequence, to inject the drugs they have 
pre-obtained prior to visiting the SIF. The benefit of this arrangement is derived from the 
provision of clean injection materials, best-practices education from the clinical staff on 
site, emergency care that is immediately available as needed, as well as stigma-free 
patient access. In addition, these facilities provide an access point to more robust 
cessation programs that is favorable to many patients because they are already typically 
                                                        
2 Luis Sordo et al., “Mortality Risk during and after Opioid Substitution Treatment: Systematic 
Review and Meta-Analysis of Cohort Studies,” The BMJ 357 (April 26, 2017), 
https://doi.org/10.1136/bmj.j1550. 
3 Tanum L et al., “Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-
Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial,” JAMA Psychiatry 74, 
no. 12 (December 1, 2017): 1197–1205, https://doi.org/10.1001/jamapsychiatry.2017.3206. 
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familiar with the facility and care experience at that SIF. Although legally no such 
facilities currently exist in the United States, current data from the Insite (SIF) facility in 
Vancouver, British Columbia suggests 88 fewer deaths per 100,000 person years, as well 
as a net public savings in spending4. Analytical models for Insite have determined that 
similar benefits are feasible with a facility in the US: hypothetical facilities in Baltimore, 
San Francisco, and elsewhere have proven to improve patient outcomes while remaining 
financially solvent. Results such as these provide the basis to argue that SIFs give 
physicians an additional degree of control in the overall treatment pathway, allowing for 
various risk factors to be mitigated via proactive efforts that compliment existing 
cessation efforts. 
 
Significance 
Although the benefit of SIFs have been established in some major metropolitan 
areas, much less research has been conducted in less densely populated regions where the 
need is either not as great or otherwise not as concentrated geospatially, especially in the 
United States where there are legal barriers obstructing the short term value of this 
information. As such, the estimated impact of a SIF in an area like the Kent County is 
largely an unknown. However, the broader opioid epidemic in the US is that the problem 
is still worsening. In 2017 67.8% of 70,237 overdose deaths were due to opioids. About 
15,000 were due to drug overdoses involving heroin— with current information from the 
Centers for Disease Control (CDC) showing some 400,000 deaths due to opioid overdose 
from 1999-2017, making it the number one form of accidental death in the country5. 
Figures as dire as these call for greater investment within existing healthcare structures, 
but also merit the consideration of feasible alternatives.  
To this end, although epidemiological methods of measuring needle / syringe 
programs (NSPs) have been around for a few decades, more recent studies have built 
                                                        
4 Jennifer Ng, Christy Sutherland, and Michael R. Kolber, “Does Evidence Support Supervised 
Injection Sites?,” Canadian Family Physician 63, no. 11 (November 2017): 866. 
5 Lawrence Scholl, “Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017,” 
MMWR. Morbidity and Mortality Weekly Report 67 (2019), 
https://doi.org/10.15585/mmwr.mm6751521e1. 
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upon Kaplan’s “Circulation Theory of Needle Exchange” in order to assess the effect of 
SIFs in a manner that also takes into consideration the impact of NSPs operating within 
the same communities67. Although the primary objective of this research is to determine 
the impact of a SIF in Kent County, MI based on a defined set of variables, a secondary 
objective will include examination of the model itself with an intent to identify potential 
modifications to the model itself, or via localized data collection methods in order to 
contribute to the discussion of how this model is applied in future research. 
In addition, data necessary for this model to be generalizable to a local area is not 
readily available at an individual location, municipal or county level, and collating data 
from state or national health agencies, and existing needle exchange facilities would help 
to better estimate the severity of the problem in this specific region. In the same way, 
investigation in this sector would highlight what information is not commonly collected 
but could be in order to improve future research on health outcomes that would also 
likely be impacted by a SIF or other similar interventions. 
While mitigating negative health outcomes is of great value to the patient 
demographic in question, it bears reminding that the treatment of these conditions are 
also associated with significant economic costs, which are at least in part borne by the 
general taxbase. The calculated impacts can be weighed against the estimated costs of 
constructing and operating this sort of facility to provide predictive and tangible 
information that may help inform future policy decisions. This information would help 
illuminate the conditions under which opening a SIF is economically solvent and a viable 
taxpayer investment using commonly collected health statistics. 
 
Methods 
As stated, Kaplan’s “circulation theory of needle exchange” takes into 
consideration a variety of behaviors common amongst people who use drugs (PWID) 
which are then employed to estimate a change in incidence within the at-risk 
                                                        
6 E. H. Kaplan and R. Heimer, “A Circulation Theory of Needle Exchange,” AIDS (London, England) 8, 
no. 5 (May 1994): 567–74. 
7 Steven D. Pinkerton, “Is Vancouver Canada’s Supervised Injection Facility Cost-Saving?,” Addiction 
105, no. 8 (2010): 1429–36, https://doi.org/10.1111/j.1360-0443.2010.02977.x. 
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subpopulation of PWID. Collecting and analyzing reliable information on each 
contributing variable presents numerous challenges in and of itself— while many of these 
variables are ascertained or extrapolated via localized health statistics, others can only be 
derived through direct communication within the PWID community itself, thus 
encouraging the use of large scale statistics collecting from the CDC and others. The 
illegal status of PWID is a significant driver in behavior for obvious reasons, but also 
adds a great deal of ethical concerns that must be adhered to for the sake of anonymity 
and privacy as well as to obtain responses demonstrating limited bias, or are reflective of 
real life. The model is given as: 
 
Disease Incidence Associated with Needle Sharing at a Given Rate: 
𝐼𝐼𝐼𝐼/𝐼𝐼𝐶𝑉 = 𝐼𝐼𝐼𝐼[1− (1−𝐼𝐼)
𝐼] 
 
Variable Value Description 
i 
HIV - 93.6093% 
HCV - 38.2% 
Proportion of PWID HIV(-) / HCV(-) 
N 978,621 Number of needles in circulation 
s 8% Rate of needle sharing 
d 17% Percentage of unclean needles 
q 
HIV - 6.39075% 
HCV - 61.8% 
Proportion of PWID HIV(+) / HCV(+) 
t 
HIV - 0.63% 
HCV - 0.57% 
Probability of HIV / HCV infection from a single injection 
M 1.3125 Number of sharing partners 
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 The “rate of needle sharing” is calculated as a “before or after intervention” by a 
separate sub equation given below: 
 
Change in the Rate of Needle Sharing: 
 
𝐼𝐼𝐼𝐼𝐼 = 𝐼𝐼𝐼𝐼
(𝐼−𝐼) + (1 −𝐼)𝐼
𝐼
 
 
Variable Value Description 
n 70% SIF client reduction in needle sharing 
N 7,301 Number of unique, annual SIF clients 
T 16,863 PWID Population (lifetime) 
 
 
PWID Population 
Definition : Estimated size of the PWID community in Kent County, Michigan 
Selected Figure : 16,863 lifetime / 1945 prior-year 
 
Given the legal status of PWID, it is undeniably difficult to estimate the size of 
the PWID population. Methods used in the past include “capture-and-release”,  the 
multiplier method, and survey meta-analysis. Previous research employing the multiplier 
method averaged several estimates of PWID numbers to determine a possible number of 
PWID in metropolitan regions8. While using additional sets of information or longer 
sampling periods can improve the accuracy of this approach, multiplier methods are 
                                                        
8 Barbara Tempalski et al., “Trends in the Population Prevalence of People Who Inject Drugs in US 
Metropolitan Areas 1992–2007,” PLOS ONE 8, no. 6 (June 5, 2013): e64789, 
https://doi.org/10.1371/journal.pone.0064789. 
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typically subject to a large degree of variability. This is similarly true of capture-and-
release, although it should also be noted that more recent attempts using this approach, 
while considered highly accurate, were used to calculate areas hit particularly hard by the 
opioid epidemic and would not be generalizable in other settings9. 
Emulating a method employed by the CDC to estimate the STI disease burden 
amongst men who have sex with men (MSM), Lansky, et al. set about a multi-phase 
process to collect usable survey data with strict exclusion criterion. Those sufficiently 
homogenous for comparison generated estimates for the amount of individuals that have 
injected drugs in the previous year as well at some point in their lives. 2.6% of the US 
population (6,612,488 individuals) are estimated to have used injection drugs at some 
point in their lives. For the past year usage was 0.30%, or 774,434 individuals― both 
estimates apply to the year 201110. Contrasted to other studies, the previous year finding 
was roughly half of Tempalski’s multiplier method estimate. It should be noted that as 
there is no accepted standard for this estimate, it could be that either study is either 
underestimating or overestimating the size of the PWID population respectively. That 
said, conservative estimates for the lifetime PWID population size of Kent County at a 
population of 648,594 stands at approximately 16,863 individuals using 2018 population 
sizes according to this approach. 
 
Proportion of PWID that are HIV+ / HCV+ 
Definition : The percentage of the Kent County PWID population that is HIV+ / HCV+  
Selected Figure :  
6.39075% HIV+ 
61.8% HCV+ 
 
                                                        
9 Lawrence Scholl, “Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017,” 
MMWR. Morbidity and Mortality Weekly Report 67 (2019), 
https://doi.org/10.15585/mmwr.mm6751521e1. 
10 Amy Lansky et al., “Estimating the Number of Persons Who Inject Drugs in the United States by 
Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus Infections,” PLoS ONE 9, no. 5 
(May 19, 2014), https://doi.org/10.1371/journal.pone.0097596. 
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Using 2016 data, the CDC reports that roughly 6.6% of HIV diagnoses were 
attributable to IDU at a national level11. Including both MSM/PWID and PWID only, the 
Michigan Department of Health and Human Services (MDHHS) reported that 11% of 
HIV prevalence in Michigan attributable to IDU (including IDU/MSM), or 7% of HIV 
prevalence attributable to IDU alone12. Applied to our estimate of the broader PWID 
population, we estimate that roughly 6.39% (~1945 individuals) of the PWID population 
in Kent County is living with HIV. A necessary caveat here is that the CDC estimates 
that one in seven individuals infected with HIV are unaware, and as such this may be 
underreported by roughly 15%. 
With regards to HCV, the CDC reports roughly 53.1% (range: 38.1%-68.0%, 95% 
CI) prevalence of HCV amongst PWID using global meta-analysis13. This rate does vary 
by report, as the CDC also reported 68.6% acute cases attributable to IDU in 2016, and 
67% globally14. At a more localized level, this seems to coincide with survey data 
collected by the MDHHS in which 62% of those diagnosed with chronic HCV also 
reported recent injection drug usage, as well as 56% of diagnosed acute cases of HCV15. 
Applying this information to the total number of cases in Kent County allows us to 
estimate the number of HIV+ / HCV+ whom are PWID as follows: 
      
  
                                                        
11 “Statistics Overview | Statistics Center | HIV/AIDS | CDC.” 2019. April 12, 2019. 
https://www.cdc.gov/hiv/statistics/overview/index.html. 
12 Michigan Dept. of Health and Human Services, “Epidemiologic Profile of HIV in Michigan”, 2018. 
13 Louisa Degenhardt et al., “Global Prevalence of Injecting Drug Use and Sociodemographic 
Characteristics and Prevalence of HIV, HBV, and HCV in People Who Inject Drugs: A Multistage 
Systematic Review,” The Lancet. Global Health 5, no. 12 (October 23, 2017): e1192–1207, 
https://doi.org/10.1016/S2214-109X(17)30375-3. 
14 Kimberly Page et al., “Injection Drug Use and Hepatitis C Virus Infection in Young Adult Injectors: 
Using Evidence to Inform Comprehensive Prevention,” Clinical Infectious Diseases: An Official 
Publication of the Infectious Diseases Society of America 57, no. Suppl 2 (August 15, 2013): S32–38, 
https://doi.org/10.1093/cid/cit300. 
15 Michigan Dept. of Health and Human Services, “Hepatitis B and C Annual Surveillance Report”, 2018 
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Kent County HIV+ / HCV+ 
Total Reported (2018) 
Condition No. 
% Attributable to PWID 
(Statewide) 
Amount due to 
PWID 
HIV+ 1130 11% 124.3 
Chronic HCV+ 454 62% 281.48 
Acute HCV+ 11 56% 6.16 
Seropositive HCV 465 61.8% 287.64 
 
While these numbers are reliant on mathematical estimations and are therefore 
inherently inexact, there is evidence that the rate of reported HCV is significantly smaller 
than the true incidence when unreported cases are also considered. Reports demonstrate 
anywhere from 12.30 actual cases per each single reported case up to 23 cases per every 
reported, as posted by the CDC and others1617. This is partially due to the infection being 
effectively asymptomatic throughout the most stages of infection up until hepatic 
function is severely impaired but also because it stands to reason that PWID would be 
less likely to voluntarily seek testing for legal and social reasons, increasing rates of 
infection within that community. 
 
Proportion of PWID that are HIV- / HCV- 
Definition : The percentage of the Kent County PWID population that is HIV- / HCV- 
Selected Figure :   
                                                        
16 R. Monina Klevens et al., “Estimating Acute Viral Hepatitis Infections From Nationally Reported 
Cases,” American Journal of Public Health; Washington 104, no. 3 (March 2014): 482–87. 
17 Brian R. Edlin et al., “Toward a More Accurate Estimate of the Prevalence of Hepatitis C in the 
United States,” Hepatology (Baltimore, Md.) 62, no. 5 (November 2015): 1353–63, 
https://doi.org/10.1002/hep.27978. 
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93.6093% HIV- 
38.1419% HCV- 
 
As specific knowledge of the number of HIV- or HCV- individuals is dependent 
on the total PWID population, an exact estimate of this value is subject to the same 
assumptions as those those given above. With that said, using our estimated PWID 
population sizes and the calculated rates of HIV+ / HCV+ individuals, the remainder 
(HIV- / HCV-) can be similarly estimated.  
 
Kent County HIV- / 
HCV- (2017) 
Outcome % of Total 
HIV- 93.6093 
Seronegative 
HCV- 
38.1419 
 
Per-Act HIV Risk 
Definition : The risk of viral transmission from a single use of a needle or syringe 
previously used by another individual infected with HIV 
Selected Figure : 0.63% 
 
 Given the differing biochemical characteristics of each virus, the rate of 
transmission is specific to the virus itself. In addition, the specific subtype of the HIV 
preeminent within any particular geographic area need also be considered for the same 
reason. Reported statistics range from 0.63%-2.4%18. On the more conservative side a 
                                                        
18 Rebecca F Baggaley et al., “Risk of HIV-1 Transmission for Parenteral Exposure and Blood 
Transfusion: A Systematic Review and Meta-Analysis:,” AIDS 20, no. 6 (April 2006): 805–12, 
https://doi.org/10.1097/01.aids.0000218543.46963.6d. 
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large study specific to the B-subtype was conducted in Thailand and found a per-act risk 
rate of 0.63%, or roughly a 1/158 chance per needle sharing event19. This figure is also 
supported by meta-analysis and has been adopted as the currently accepted CDC rate20. 
Given that this 0.63% figure is sufficiently sampled, of the subtype predominant in North 
America, conservative compared to other measures, and is accepted as the current 
standard, it is the preferred number to use for this analysis short of having highly 
localized data available or otherwise conducting a test using weighted prevelances of 
each subtype. 
 
Per-Act HCV Risk 
Definition : The risk of viral transmission from a single use of a needle or syringe 
previously used by another individual infected with HCV 
Selected Figure : 0.57% 
 
Accidental needlestick injuries are commonly recorded in clinical environments 
as workplace accidents, and thus might act as reliable data on HCV transmission. 
Available data from the CDC provides a cumulative risk of roughly 1.8% per act via 
needlestick injury to health care workers. However, it should be noted that there are 
notable differences in how and where those injections occurred (predominantly the hand, 
neck, or face in that setting), and thus it may not accurately reflect the risk to sharing 
injection equipment2122. Current literature specific to transmission among PWID suggests 
some conjecture over this figure, likely due to the wide variance in reporting methods 
                                                        
19 Michael G. Hudgens et al., “Estimating the Transmission Probability of Human Immunodeficiency 
Virus in Injecting Drug Users in Thailand,” Journal of the Royal Statistical Society: Series C (Applied 
Statistics) 50, no. 1 (2001): 1–14, https://doi.org/10.1111/1467-9876.00216. 
20 Pragna Patel et al., “Estimating Per-Act HIV Transmission Risk: A Systematic Review,” AIDS 28, no. 
10 (June 2014): 1509–19, https://doi.org/10.1097/QAD.0000000000000298. 
21 Francesco M. Egro et al., “Seroconversion Rates among Health Care Workers Exposed to Hepatitis 
C Virus–Contaminated Body Fluids: The University of Pittsburgh 13-Year Experience,” American 
Journal of Infection Control 45, no. 9 (September 1, 2017): 1001–5, 
https://doi.org/10.1016/j.ajic.2017.03.011. 
22 Fenton M. O’Leary and Timothy C. Green, “Community Acquired Needlestick Injuries in Non-Health 
Care Workers Presenting to an Urban Emergency Department,” Emergency Medicine 15, no. 5–6 
(2003): 434–40, https://doi.org/10.1046/j.1442-2026.2003.00498.x. 
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amongst users. Boelen, et al. found a rate of roughly 0.57%, or 1/175, admitting that the 
risk may be as high as 6% per act23. Given the asymptomatic nature of HCV, it stands to 
reason that a transmission rate lower than HIV could still result in a far greater number of 
total infections and so a conservative estimate may not be as unrealistic as it would 
initially appear. 
 
Percent Needles Uncleaned 
Definition : The probability that a used needle or syringe was not disinfected bleached 
before reuse by a secondary party 
Selected Figure : 17% 
 
Bleach has proven to be an effective disinfection measure for injection equipment 
and is thus employed regularly for disinfection by PWID24. The low cost and high 
effectiveness of bleach led to the mass distribution of “bleach kit” programs long before 
more modern needle exchange services were created, which fill of distributing these kits 
in many locations across the US. Despite ease of availability, the frequency of effective 
disinfection of injection materials is not 100%. While it is reasonable to suggest that SIF 
users would likely have a heightened rate of bleaching, it likely be similar to rate among 
users of existing NSPs because there would be a large overlap in the types of materials 
distributed as well as risk-mitigation education efforts by these respective services. 
Previous studies have estimated a percentage of unclean needles used via survey data to 
be roughly 17%, or that 83% of the time needles are adequately bleached prior to reuse.25 
 
                                                        
23 Lies Boelen et al., “Per-Event Probability of Hepatitis C Infection during Sharing of Injecting 
Equipment,” PLOS ONE 9, no. 7 (July 7, 2014): e100749, 
https://doi.org/10.1371/journal.pone.0100749. 
24 Holly Hagan, Enrique R. Pouget, and Don C. Des Jarlais, “A Systematic Review and Meta-Analysis of 
Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs,” The Journal of 
Infectious Diseases 204, no. 1 (July 1, 2011): 74–83, https://doi.org/10.1093/infdis/jir196. 
25 Martin A. Andresen and Neil Boyd, “A Cost-Benefit and Cost-Effectiveness Analysis of Vancouver’s 
Supervised Injection Facility,” International Journal of Drug Policy 21, no. 1 (January 1, 2010): 70–76, 
https://doi.org/10.1016/j.drugpo.2009.03.004. 
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Needles in Circulation 
Definition : The number of needles or syringes in circulation amongst the PWID 
community, distributed by NSP’s or other available services 
Selected Figure : 978,621 
 
Alongside many other states, Michigan has legal provisions supporting the sale of 
syringes without prescription at pharmacies and other facilities selling medical supplies, 
and as such there is no method of accurately determining whether any syringe sale is 
intended for medical or illicit use. This being the case, it’s difficult to ascertain just how 
many syringes are in circulation across the entire the PWID community. However this 
can be estimated using local NSP data because it can be assumed that procurement 
behavior amongst PWID via NSPs and SIFs would be similar, and that their geospatial 
reach in terms of needle distribution would be similar. 
“Clean Works”, the only NSP operating within Kent County, operates in various 
spots surrounding Grand Rapids, Michigan. Clean Works reports roughly 300,000 
syringes distributed annually, or roughly 1.501 syringes per person, per year26. Applying 
a similar rate to Kent County with regards to the difference in population yields an 
approximate estimate of 978,621 syringes distributed across the county. It should be 
noted that Clean Works has adopted a system of operating a model unit with a rotating 
schedule of locations based on relative PWID demand across different locations within 
the city and so while a SIF would provide a similar service, it would presumably be 
limited to a static location. In addition, it is assumed that broader Kent County has 
roughly the same per capita PWID as the more urban Grand Rapids area, which is a 
query that ought be subject to further investigation.  
 
Frequency of Share Events 
Definition : The percent likelihood that any instance of injection drug use is a shared 
(receptive) injection 
                                                        
26 “Red Project, “Syringe Access, HIV Test, Overdose Prevention”, accessed 23 July, 2019.) 
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Selected Figure : 8.00% 
 
Given the high correlation between IDU and communicable diseases, various 
social behaviors amongst PWID play a unique and prominent role in viral transmission. 
As such, a great deal of data is collected on the frequency of needle-sharing, although this 
rate varies amongst study groups and is also notably dependent on the duration any 
particular cohort was surveyed. Analysis from interviews of >12,000 individual PWID 
yielded a sharing rate of roughly 31.9% in the last thirty days, or up to 64.5% within the 
previous six months2728. While it is obvious that the likelihood sharing may have 
occurred increases with time, Nguyen et al. worked in conjunction with the CDC to 
extrapolate an estimated rate of 8-13% share rate per injection by way of incorporating 
reported daily injection averages and share rates across multiple groups across 19 US 
cities29. 
 
Number of Sharing Partners 
Definition : The average number of individuals injecting in a single assembly or session 
Selected Figure : 1.3125 
 
In order to fully characterize patterns of behavior in injection drug use, it is 
necessary to consider the number of partners included in any particular session. To 
illustrate the relevance of this variable, consider a situation where four individuals in one 
setting might share the same set of injection equipment, and the added risk to the fourth 
individual to use that set equipment as compared to the second individual (or first, if the 
equipment used is not sterile to begin with).  
                                                        
27 Trang Quynh Nguyen et al., “Syringe Exchange in the United States: A National Level Economic 
Evaluation of Hypothetical Increases in Investment,” AIDS and Behavior 18, no. 11 (November 2014): 
2144–55, https://doi.org/10.1007/s10461-014-0789-9. 
28 Shruti H. Mehta et al., “Changes in Blood-Borne Infection Risk Among Injection Drug Users,” The 
Journal of Infectious Diseases 203, no. 5 (2011): 587–94. 
29 Trang Quynh Nguyen et al., “Syringe Exchange in the United States: A National Level Economic 
Evaluation of Hypothetical Increases in Investment,” AIDS and Behavior 18, no. 11 (November 2014): 
2144–55, https://doi.org/10.1007/s10461-014-0789-9. 
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The amount of information on this particular topic is very thin— while there is a 
wealth of data supporting the rate of receptive sharing (both over the course of a lifetime 
and in say, the last month), this is inadequate to describe the number of individuals 
participating in a single exchange. One study found a ratio of roughly 1.3125 receiving to 
giving injection equipment in Montreal, Quebec30. This population would have some 
overlap with Insite’s clientele base, and represents the more conservative number then 
other studies surveying smaller populations or at earlier points in time31. It should be 
noted that all known material published on this subject has been collected from NSP’s, so 
it is currently unknown whether SIF usage may impact this behavior differently.  
 
Number of SIF Clients 
Definition : The annual number of unique visitors to an existing SIF 
Selected Figure : 7301 unique, annual clients 
 
In other modeling studies, this figure has been reported as a monthly total of 
unique visitors3233. However, there are several issues with this approach. First, any 
change in the incidence of HIV or HCV is being reported as cases prevented annually, so 
it is more consistent to not convert between differing units of time unnecessarily. In 
addition, Vancouver Coastal Health (VCH; the regional state health authority that 
includes Vancouver’s DTES and Insite) reported an annual total of 7,301 unique visitors 
                                                        
30 Prithwish De et al., “HIV and HCV Discordant Injecting Partners and Their Association to Drug 
Equipment Sharing,” Scandinavian Journal of Infectious Diseases 41, no. 3 (2009): 206–14, 
https://doi.org/10.1080/00365540902721376. 
31 Amos Irwin et al., “A Cost-Benefit Analysis of a Potential Supervised Injection Facility in San 
Francisco, California, USA,” Journal of Drug Issues 47, no. 2 (April 2017): 164–84, 
https://doi.org/10.1177/0022042616679829. 
32 Amos Irwin et al., “Mitigating the Heroin Crisis in Baltimore, MD, USA: A Cost-Benefit Analysis of a 
Hypothetical Supervised Injection Facility,” Harm Reduction Journal 14, no. 1 (12 2017): 29, 
https://doi.org/10.1186/s12954-017-0153-2. 
33 Amos Irwin et al., “A Cost-Benefit Analysis of a Potential Supervised Injection Facility in San 
Francisco, California, USA,” Journal of Drug Issues 47, no. 2 (April 2017): 164–84, 
https://doi.org/10.1177/0022042616679829. 
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(2017)34. Because some percentage of the first month’s visitors likely returned and are 
thus contained within VCH’s reported 7,301 annual unique clients, using one month for 
calculation and then converting to an annual unit value is effectively inflating the benefit 
of the SIF artificially due to the fact that it is seemingly unlikely that Insite or another SIF 
would maintain a consistent standard of roughly 1,700-2,100 unique visitors throughout 
the remainder of the year.  
 
SIF Client Reduction in Needle Sharing 
Definition : The PWID-reported decrease in injection equipment sharing as a result of 
SIF usage or SIF-mediated education initiatives 
Selected Figure : 70% reported decrease in needle / syringe sharing 
 
At the heart of any hypothetical model such as this lie some core assumptions that 
must be made due to the inherent lack of comparative information. As there are no legally 
sanctioned SIFs in the US at this time (much less in the West Michigan area), it is 
impossible to say whether a SIF in this area would have a similar impact on individual 
behavior as Vancouver’s Insite, or whether that facility would be as well-regarded within 
the PWID population in that area. Kerr et al. reported a 70% reduction in sharing at the 
Insite facility, a figure that has been reused in modeling for a number of other SIFs35. 
This information was subsequently reviewed independently in meta-analysis, and is thus 
accurately representative of Insite’s role36.  
 
  
                                                        
34 “Insite User Statistics - Vancouver Coastal Health.” n.d. Accessed June 25, 2019. 
http://www.vch.ca/public-health/harm-reduction/supervised-consumption-sites/insite-user-
statistics. 
35 Thomas Kerr et al., “Safer Injection Facility Use and Syringe Sharing in Injection Drug Users,” The 
Lancet 366, no. 9482 (July 2005): 316–18, https://doi.org/10.1016/S0140-6736(05)66475-6. 
36 Chloé Potier et al., “Supervised Injection Services: What Has Been Demonstrated? A Systematic 
Literature Review,” Drug and Alcohol Dependence 145 (December 1, 2014): 48–68, 
https://doi.org/10.1016/j.drugalcdep.2014.10.012. 
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Results 
Implementation of a SIF in the Kent County area was found to reduce the 
frequency of sharing events by roughly 2.5%. The decrease in sharing, subsequently, 
would result in a decrease of HCV and HIV incidence attributable to IDU by 
approximately 30%. For clarity, as MDHHS report 47 total incident HIV diagnoses were 
made in 2017 and only a small percentage of those were due to IDU, this represents a 
roughly 5% decrease in HIV diagnoses. With roughly 60% of HCV diagnoses being 
associated with IDU, calculations show a flat decrease in 7 incident cases, but the actual 
impact of this could vary much more widely due to high transmission of HCV as well as 
heightened rates of education and testing services that a SIF could provide to the PWID 
community that are difficult to administer currently due to legal and social concerns of 
that population. Perhaps most importantly, results here are purely analytical in nature and 
would have limited predictability. One especially noteworthy reason for this is that that 
drug policy in the US differs significantly from Canada, and developing trust between an 
SIF and local PWID is a relationship that would take some time to nurture and mature.  
 
Discussion 
 While a handful of studies modeling SIFs in the US have been published, there is 
still a great deal of work to do with regard to determining best practices. Such studies 
have inherent blind spots, and while that is acceptable in the sense that more 
comprehensive data is as of yet unavailable, it simultaneously highlights the need for 
increased time and resource investment, given the relative success of SIFs north of the 
border. At this time, most existing data comes via major metropolitan areas, and the 
demand for a broadened tool kit is likely felt most acutely in dense urban environments, it 
remains true that lower boundaries of the positive impact of SIFs provides valuable 
information to policymakers and a wide assortment of local stakeholders. As such, future 
studies would do well to consider the broader implications of SIFs, including impacts on 
PWID behavior and third party effects, including those on local health providers, first 
responders, and other associated parties.  
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Limitations 
 Given the limited local data available, the results of this test should be considered 
subjective and preliminary in nature. While Kent County and Vancouver have similar 
population sizes, there is a great difference in population density and this would likely 
have a strong impact on PWID attendance and retention with any SIF, which would 
ideally be built in the highest concentrated area of need to provide the greatest impact. 
Similarly, as Kent County is made of urban, suburban, and rural areas, the per capita 
PWID within each geographic subregion is not likely to be consistent and should be 
studied more in depth to help define those areas of greatest need. Finally, it is 
questionable whether a Kent County SIF would result in a similar reduction on injection 
equipment sharing. 
 On the opposing side, this study also does not detail a comprehensive list of 
changes that may occur with the addition of a SIF. Most notably, SIFs have also shown to 
decrease drug overdoses, and soft skin and tissue infections that are also extremely 
common amongst injection drug users. Other benefits may also include decreases in 
hospital bed stay and first responder expenses, both of which are also often absorbed by 
the general tax base. SIFs and NSPs would also impact biohazard waste, decreasing the 
amount of used drug supplies discarded in public areas, decreasing risk to others and 
helping maintain clean urban environments.  
 In addition to those mentioned above, future studies could improve this test with 
further localization of data. The rate of equipment sharing, number of sharing partners, 
likelihood of bleaching shared equipment, and number of needles in circulation are all 
specific to differing populations and are impacted by outside confounders (such as the 
local economy or job market), and with significant ethical considerations in place this 
information could be surveyed anonymously via local NSPs. Ideally, surveys would be 
completed at multiple points in time or over long periods in order to produce large 
averages or detect changes in behavioral patterns over time within a given survey area.  
 
